Are we ready to RESPOND that the question of abacavir's role in cardiovascular disease events is settled?
- PMID: 36695364
- DOI: 10.1097/QAD.0000000000003448
Are we ready to RESPOND that the question of abacavir's role in cardiovascular disease events is settled?
Comment on
-
Recent abacavir use and incident cardiovascular disease in contemporary-treated people with HIV.AIDS. 2023 Mar 1;37(3):467-475. doi: 10.1097/QAD.0000000000003373. Epub 2022 Aug 23. AIDS. 2023. PMID: 36001525
References
-
- Triant VA. Editorial: HIV and cardiovascular disease: recognizing and reducing disparities . Curr Opin HIV AIDS 2022; 17:259–260.
-
- Dirajlal-Fargo S, Funderburg N. HIV and cardiovascular disease: the role of inflammation . Curr Opin HIV AIDS 2022; 17:286–292.
-
- Triant VA, Regan S, Lee H, Sax PE, Meigs JB, Grinspoon SK, et al. Association of immunologic and virologic factors with myocardial infarction rates in a US healthcare system . J Acquir Immune Defic Syndr 2010; 55:615–619.
-
- David MH, Hornung R, Fichtenbaum CJ. Ischemic cardiovascular disease in persons with human immunodeficiency virus infection . Clin Infect Dis 2002; 34:98–102.
-
- Subramanian S, Tawakol A, Burdo TH, Abbara S, Wei J, Vijayakumar J, et al. Arterial inflammation in patients with HIV . JAMA 2012; 308:379–386.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
